Abstract:Abstract Background The purpose of this study was to investigate the ability of differential diagnosis of prostate specific antigen decline rate (PSADR) per week, degree of prostatic collapse (DPC) and tissue signal rate of prostate (TSRP) between prostatitis and prostate cancer. Methods The clinical data of 92 patients [prostate specific antigen (PSA) > 10 ng/mL] who underwent prostate biopsy in the Department of Urology, the Second Affiliated Hospital of Xi ’an Jiaotong University from May 2017 to April 2020 were reviewed retrospectively. They were divided into two groups, prostatitis group ( n = 42) and prostate cancer (PCa) group ( n = 50), according to pathological results. Parameters, like patient characteristics, PSADR, DPC, TSRP and infectious indicators, were compared and analyzed by t test or non-parametric test to identify if there were significant differences. The thresholds of parameters were determined by the receiver operating characteristic curve (ROC), and the data were analyzed to investigate the diagnostic value in distinguishing of prostatitis and prostate cancer. Results There were statistical differences in age, PSADR, DPC, TSRP, neutrophil percentage in serum, white blood cell (WBC) in urine and prostate volume between prostatitis group and PCa group ( P < 0.001, < 0.001, = 0.001, 0.001, 0.024, 0.014, < 0.001 respectively). There was no statistical difference in serum WBC count, serum neutrophil count, monocyte percentage and urine bacterial count between two groups ( P = 0.089, 0.087, 0.248, 0.119, respectively). Determined by ROC curve, when the thresholds of PSADR per week as 3.175 ng/mL/week, DPC as 1.113, TSRP as 2.708 were cutoffs of distinguishing prostatitis and prostate cancer. When combining these three indexes to diagnose, the accuracy rate of diagnosis of prostatitis was 78.85%, the accuracy rate of diagnosis of prostate cancer was 97.50%. Univariate analysis suggested that PSADR, DPC and TSRP played an important role in differentiating prostate cancer from prostatitis ( P 3.175 might be good indicators when distinguishing prostate disease with prostatitis (OR = 14.305, 95%CI = 3.779 ~ 54.147), while DPC > 1.113 and TSRP > 2.708 might be associated with a higher risk of prostate cancer (OR = 0.151, 95%CI = 0.039 ~ 0.588; OR = 0.012, 95%CI = 0.005 ~ 0.524, respectively). Conclusion The combination of PSADR per week, DPC, and TSRP might be helpful to distinguish prostate cancer and prostatitis, and can reduce unnecessary invasive and histological procedure.

Study On The Diagnostic Value Of Various Volume-Adjusted Psa Derivatives In Prostate Cancer In South Chinese Populations

Multivariate study of factors affecting the results of prostate biopsy in PSA grey zone

Diagnostic value comparison of PSAM and PSAMR on PSA grey zone in prostate cancer by ROC curve analysis

Applied Research of Prostate Specific Antigen Combined with Prostate Cancer Gene 3 in Diagnosis of Prostate Disease

Current status of prostate biopsy in Chinese Prostate Cancer Consortium member hospitals

Percent Free Prostate-Specific Antigen for Prostate Cancer Diagnosis in Chinese Men with a PSA of 4.0–10.0 Ng/ml: Results from the Chinese Prostate Cancer Consortium

The Influence of Prostate Volume on Cancer Detection in the Chinese Population.

The Use of Prostate Specific Antigen (PSA) Density in Detecting Prostate Cancer in Chinese Men with PSA Levels of 4–10 Ng/ml

Evaluation of PSA-age Volume Score in Predicting Prostate Cancer in Chinese Population

Age-Specific Cutoff Value for the Application of Percent Free Prostate-Specific Antigen (PSA) in Chinese Men with Serum PSA Levels of 4.0-10.0 Ng/ml.

The value of adjusted PSAD in prostate cancer detection in the Chinese population

A multicenter retrospective study on evaluation of predicative factors for positive biopsy of prostate cancer in real-world setting

Prostate-specific Antigen Velocity (PSAV) and PSAV Per Initial Volume (PSAVD) for Early Detection of Prostate Cancer in Chinese Men.

Clinical Study on PSA for the Early Diagnosis of Prostate Cancer

The Comparative Study on the Application Value of Transperineal Prostate Combined Biopsy and Transrectal Prostate Systematic Biopsy in Diagnosing Prostate Cancer in Patients with Different PSA Zones.

The Predictive Value of Prostate Specific Antigen Transition Zone Density in Prostate Biopsy

A preliminary study on the diagnostic value of PSADR, DPC and TSRP in the distinction of prostatitis and prostate cancer

Risk Assessment Models to Evaluate the Necessity of Prostate Biopsies in North Chinese Patients with 4-50 Ng/ml PSA

Comparative analysis of PSA and ultrasound-guided biopsy diagnosis of prostate cancer

Additional Value of the Ratio of Serum Total Testosterone to Total Prostate-Specific Antigen in the Diagnosis of Prostate Cancer in a Chinese Population

Value of Multi-Biomarkers Plus PSA in the Diagnosis of Prostate Cancer